TRS Stock Recent News
TRS LATEST HEADLINES
MILAN & MORRISTOWN, N.J.--(BUSINESS WIRE)---- $NWRN #schizophrenia--Newron begins enrollment in pivotal Phase III ENIGMA-TRS program with evenamide as add-on therapy for treatment-resistant schizophrenia (TRS).
The outlook of the Zacks Metal Products - Procurement and Fabrication industry looks upbeat and stocks like ESAB, TRS and KALU are worth keeping an eye on.
TriMas Corporation (NASDAQ:TRS ) Q2 2025 Earnings Conference Call July 29, 2025 10:00 AM ET Company Participants Sherry Lauderback - Vice President of Investor Relations, Communications & Sustainability Teresa M. Finley - CFO, Treasurer & Director Thomas J.
TriMas (TRS) came out with quarterly earnings of $0.61 per share, beating the Zacks Consensus Estimate of $0.5 per share. This compares to earnings of $0.43 per share a year ago.
BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--TriMas (NASDAQ: TRS) today announced financial results for the second quarter ended June 30, 2025. The Company reported second quarter 2025 net income of $16.7 million, or $0.41 per diluted share, compared to $10.9 million, or $0.27 per diluted share, in second quarter 2024. Adjusting for Special Items(1), second quarter 2025 adjusted net income(2) was $25.1 million, compared to $17.5 million in second quarter 2024. Second quarter 2025 adjusted diluted.
BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--TriMas (NASDAQ: TRS) today declared a quarterly cash dividend of $0.04 per share of TriMas Corporation stock. The quarterly dividend is payable on August 12, 2025, to shareholders of record as of the close of business on August 5, 2025. About TriMas TriMas manufactures a diverse set of products primarily for the consumer products, aerospace and industrial markets through its TriMas Packaging, TriMas Aerospace and Specialty Products groups. Our approxima.
BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--TriMas (NASDAQ: TRS) announced today that it will host its second quarter 2025 earnings conference call on Tuesday, July 29, 2025. The conference call will begin at 10 a.m. Eastern Time and will follow the Company's release of second quarter 2025 earnings results at 8 a.m. that day. To participate on the earnings conference call, please dial: (877) 407-0890 (U.S. and Canada) or +1 (201) 389-0918 (outside the U.S. and Canada) and ask to be connected to t.
BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--TriMas (NASDAQ: TRS) today announced that, as previously disclosed in a Current Report on Form 8-K filed on June 9, 2025 with the Securities and Exchange Commission, the Company has made an inducement grant to Thomas Snyder, the newly-appointed President and Chief Executive Officer of TriMas. As approved by the Company's Board of Directors and Compensation Committee pursuant to Rule 5635(c)(4) of the Nasdaq Stock Market Listing Rules, the inducement gra.
TriMas stock remains a soft 'buy' due to ongoing strategic review and potential catalysts, despite recent share price appreciation. Aerospace segment drove strong Q1 revenue growth, while Packaging saw modest gains and Specialty Products contracted due to divestiture. Profitability improved year-over-year, with net income and EBITDA rising, and management forecasts further earnings growth for 2025.